1,28,70,000(75.0%)
42,90,000(25.0%)
1,71,60,000
Sopan Pharmaceuticals Limited (SOPL) is listed under "Manufacturing And Processing" sector at Nepal Stock Exchange (NEPSE) on June 05, 2026 with a market capitalization of NPR 9,12,39,72,000 (9.1 Arab) and a float market capitalization of NPR 2,28,09,93,000 (2.3 Arab). It has a total of 1,71,60,000 (1.7 Crore) listed shares, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.
Sopan Pharmaceuticals Limited (SOPL) has a total market capitalization of NPR 9,12,39,72,000 (9.1 Arab) and a float market capitalization of NPR 2,28,09,93,000 (2.3 Arab). The book value stands at 92.15, resulting in a price-to-book value (PBV) of 5.77. The face value of each share is Rs. 100.
A total of 1,71,60,000 (1.7 Crore) shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.
As of June 12, the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL) is Rs. 531.7 (69.3, 14.99%). Today, the stock opened at Rs. 471.3, reached a high of Rs. 531.7, and a low of Rs. 471.3. The previous closing price was Rs. 462.4, with a turnover of Rs. 198665 and a trading volume of 380 shares across 38 trades.
Over the past year, Sopan Pharmaceuticals Limited (SOPL) has seen a 52-week high of Rs. 531.7 and a low of Rs. 276.5. The all-time high was Rs. 531.7 on June 12, 2026, while the all-time low was Rs. 276.5 on June 08, 2026. The 120-day average price is Rs. 410, and the 180-day average is Rs. 410. The 1-year yield is currently 74.84%.
Sopan Pharmaceuticals Limited (SOPL) has an earnings per share (EPS) of 18.33 and a P/E ratio of 29.01. The book value per share is 92.15, and the price-to-book value (PBV) is 5.77. The stock's 1-year yield is 74.84%, and its fiscal year data is reported for 081/82, Q4. The paid-up capital is Rs. 1,71,60,00,000.
